Home Visit
Upload
CDX2 IHC
No special precautions
Recommended for
Male, Female
Report
Within 1 Week
Blood test at Home
NABL & CAP Accredited Labs
Accurate & Quality Test Reports
Trusted by Leading Doctors & Hospitals
Overview
The CDX2 IHC test is a laboratory procedure that utilizes antibodies to detect the presence of CDX2, a protein found in the nuclei of epithelial cells throughout the intestine, from duodenum to rectum. CDX2 is a homeobox transcription factor that plays a crucial role in intestinal development and differentiation. It is expressed in normal intestinal epithelial cells, including absorptive, endocrine, and Paneth cells. CDX2 is a sensitive and specific marker used for diagnosing and monitoring gastric and colorectal carcinomas.
CDX2 IHC Price
Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the CDX2 IHC with a clear pricing structure.
The CDX2 IHC Price in Thalassery is ₹ 2,265 .
We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.
Frequently Asked Questions
This test measures the presence of CDX2, a protein marker, in tissue samples. The results provide valuable information about the presence and extent of various types of cancer.
This test is mainly performed to:
- Detect and diagnose gastric and colorectal carcinomas
- Monitor the effectiveness of treatment for these types of cancers
- Determine the presence of CDX2 in tumours that affect the gastrointestinal tract
- Guide further treatment decisions and prognosis
Your doctor may recommend this test if you:
- Have symptoms or risk factors associated with gastric or colorectal carcinomas
- Require an accurate diagnosis or staging of these cancers
- Need to assess the effectiveness of treatment
- Want to evaluate the suitability for targeted therapies
Abnormal results may indicate the presence of gastric or colorectal carcinomas. However, additional tests, such as imaging scans and biopsies, are often necessary to confirm the diagnosis. It's important to discuss your test results with your doctor for a comprehensive evaluation and appropriate follow-up care.
During this test:
- Your doctor will take a tissue sample from your previous biopsy or surgery.
- The sample will be sent to the laboratory for analysis using immunohistochemistry techniques.
- The results will be reported on the fourth day.
There are no specific preparations required for this test. However, you should provide your original histopathology report and any relevant clinical and radiological details to aid in the accurate interpretation of the results. Follow all instructions provided by your doctor or healthcare provider.
- Molecular biomarker testing: This helps identify specific genetic mutations or alterations in tumours.
- Imaging scans (CT, MRI): These imaging tests can provide detailed information about the extent and spread of cancer.
- Blood tests (CEA, CA 19-9): These tests measure tumour markers associated with gastrointestinal cancers.
- CDX2 immunohistochemistry
- CDX2 IHC
Gastric carcinoma is a type of cancer that originates in the stomach lining, while colorectal carcinoma refers to cancer of the colon or rectum. Both of these types of carcinomas can cause various symptoms and require accurate diagnosis for timely treatment and management.
Ratings & Reviews (0)
Why Metropolis?
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.
WhatsApp
